Effect of Platelet Rich Plasma versus Conventional Therapy on Early and Late ME 49 Toxoplasma Gondii Infection in Immunocompromised Mice

THERAPEUTIC EFFICACY OF RESIQUIMOD ON TREATING CHRONIC TOXOPLASMOSIS IN EXPERIMENTAL INFECTED MICE

EFFICACY OF AZITHROMYCIN ON EXPERIMENTAL TOXOPLASMOSIS INFECTED MICE

EFFECTS OF INTRAMUSCULAR INJECTION OF PLATELET-RICH PLASMA ON LARVAL BURDEN OF TRICHINELLA SPIRALIS IN EXPERIMENTALLY INFECTED MICE

The efficacy of platelet rich plasma as adjuvant therapy in the treatment of cryptosporidiosis in experimentally infected immunosuppressed rats

THE EFFECT OF CLINDAMYCIN AND SULFADIAZINE ON EXPERIMENTAL MURINE MODEL WITH ACUTE TOXOPLASMOSIS

CIPROFLOXACIN-LOADED SILVER NANOPARTICLES EFFICACY ON CHRONIC TOXOPLASMOSIS INFECTED MICE

EFFICACY OF TOPOISOMERASE INHIBITOR II (LEVOFLOXACIN) COMBINED WITH ALLIUM SATIVUM ON EXPERIMENTAL CEREBRAL TOXOPLASMOSIS INFECTED MICE

EFFICACY OF SOME DRUGS AND PATHOLOGICAL STUDIES ON TOXOPLASMA GONDII INFECTION IN MICE

The therapeutic efficacy of curcumin nanoemulsion versus Spiramycin in Toxoplasma gondii (ME49 strain) chronically infected mice